Roger Briesewitz PhD

Roger Briesewitz PhD
Senior Res ScientistOfc of Health Sciencesbriesewitz.1@osu.edu
Comprehensive Cancer Center 410 W 12th Avenue Columbus Ohio 43210
Phone:614-688-4395Fax: (614) 292-7232
  • Non-Member

Current Publications

  • Oaks JJ, Santhanam R, Walker CJ, Roof S, Harb JG, Ferenchak G, Eisfeld AK, Van Brocklyn JR, Briesewitz R, Saddoughi SA, Nagata K, Bittman R, Caligiuri MA, Abdel-Wahab O, Levine R, Arlinghaus RB, Quintas-Cardama A, Goldman JM, Apperley J, Reid A, Milojkovic D, Ziolo MT, Marcucci G, Ogretmen B, Neviani P, Perrotti DAntagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.Blood 122 1923-34 9/12/2013
  • Qian Z, Liu T, Liu YY, Briesewitz R, Barrios AM, Jhiang SM, Pei DEfficient delivery of cyclic peptides into mammalian cells with short sequence motifs.ACS Chem Biol 8 423-31 2/15/2013
  • Wu X, Upadhyaya P, Villalona-Calero MA, Briesewitz R, Pei DInhibition of Ras-Effector Interaction by Cyclic Peptides.Medchemcomm 4 378-382 2/1/2013
  • Chao BH, Briesewitz R, Villalona-Calero MARET fusion genes in non-small-cell lung cancer.J Clin Oncol 30 4439-41 12/10/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu